Lowenstein Sandler represented Maxim Group LLC as sole book-running manager for the $13.1 million underwritten public offering for Provectus Biopharmaceuticals Inc. The Lowenstein deal team included Steven M. Skolnick, Robert J. Paradiso, James B. O'Grady, Irina Ishak and Brandon Greenblatt.
Relevant Insights
-
PROFESSIONALS | Lawyers
Access the profiles of the more than 350 Lowenstein Sandler lawyers who provide critical legal counsel to clients in virtually every sector of the global economy...
-
NEWS & INSIGHTS | Firm News
Discover the latest updates and developments about Lowenstein Sandler...
-
NEWS & INSIGHTS | Publications
Access our insightful thought leadership, including articles, client alerts, and blog posts...